首页> 外文期刊>International endodontic journal >Is a calcium hydroxide liner necessary in the treatment of deep caries lesions? A systematic review and meta‐analysis
【24h】

Is a calcium hydroxide liner necessary in the treatment of deep caries lesions? A systematic review and meta‐analysis

机译:是一种氢氧化钙衬里,在治疗深龋病病变时是必要的吗? 系统审查和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract The aim of this systematic review and meta‐analysis was to evaluate whether the use of calcium hydroxide ( CH ) liner improves the clinical success in the treatment of deep caries lesions of primary and permanent teeth. The review was reported in accordance with the PRISMA Statement. Only studies that evaluated deep carious lesions treated with and without a CH liner were included. The required outcomes had to be obtained by clinical, radiographic or laboratory evaluations. Statistical analyses were performed with the RevMan 5.2 program (The Cochrane Collaboration, Copenhagen, Denmark) for randomized clinical trials with at least 12?months of follow‐up, using fixed‐effect models at a significance level of P ??0.05. The literature search was performed in eight databases: PubMed (MEDLINE), Lilacs, IBECS , BBO , Web of Science, Scopus, Sci ELO and The Cochrane Library. A total of 17 studies were included (15 in primary teeth, two in permanent teeth). The overall risk difference for CH versus adhesive system in primary teeth was 0.06 [95% CI ?0.01 to 0.13], and the overall risk difference for CH versus GIC was 0.10 [95% CI ?0.01 to 0.22], with no significant differences between materials. CH liner did not influence the clinical success of treatment for deep caries lesions of primary or permanent teeth. Although the present analysis demonstrated that use of CH liner in deep caries lesions was unnecessary, the evidence was of moderate to very low quality; thus, further well‐designed, randomized and controlled clinical trials are necessary to provide stronger recommendations.
机译:摘要这种系统评价和荟萃分析的目的是评估氢氧化钙(CH)衬里的使用是否改善了临床成功,治疗初级和永久性的深龋病病变。审查是根据PRISMA陈述报告的。只有在没有CH衬里治疗的评估深龋病病变的研究才有。必须通过临床,射线照相或实验室评估获得所需的结果。使用Revman 5.2程序(Cochrane Collaboration,Copenhagen,Denmark)进行统计分析,用于随机临床试验,其中至少12?几个月的随访,使用固定效果模型在PΔ≤0.05的显着性水平。文献搜索是在八个数据库中进行的:PubMed(Medline),淡紫色,IBECS,BBO,科学网站,Scopus,SCI ELO和Cochrane图书馆。共用了17项研究(初级牙齿15例,恒牙两个)。初级牙齿上的CH与粘合剂系统的总体风险差异为0.06 [95%CI〜0.13],并且CH与GIC的总体风险差为0.10 [95%CI〜0.01至0.22],之间没有显着差异材料。 CH衬里没有影响初级或常牙牙齿的深龋病病变的临床成功。虽然目前的分析表明,不需要使用CH衬里的CH衬里,证据具有中等至非常低的质量;因此,需要进一步设计,随机和受控的临床试验,以提供更强大的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号